查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032990

無針給藥技術市場規模、佔有率、趨勢和預測：按產品、應用、最終用戶和地區分類，2026-2034年

Needle-Free Drug Delivery Technology Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球無針給藥技術市場規模為48億美元。展望未來，IMARC Group預測，該市場將在2026年至2034年間以4.25%的複合年成長率成長，到2034年達到71億美元。目前，北美市場主導地位，預計2025年將佔43.4%的市場。推動此市場成長的因素包括：對無痛給藥方式的需求不斷成長、感染控制意識的提高以及自我給藥系統的日益普及。生物技術的進步和設備精度的提高，透過改善患者依從性和治療效果，進一步促進了無針給藥技術市場佔有率的成長。

全球慢性病（尤其是糖尿病）盛行率的上升，推動了對高效無痛給藥方式的需求。無針技術為傳統注射方式提供了一種替代方案，提高了患者的依從性和舒適度。對於需要定期用藥的慢性病患者，無針系統提供了更便捷的選擇，從而改善了患者的生活品質。此外，噴射注射器、經皮吸收貼片和各種無針裝置的不斷進步，提高了給藥的準確性、安全性和劑量精確度。這些創新增強了藥物吸收，最大限度地減少了藥物浪費，並確保了可靠的給藥，從而提高了治療效果和患者依從性。此外，將無針給藥系統與數位健康解決方案結合，可實現即時監測、資料收集和個人化治療方案的製定，從而改善患者的治療效果和用藥依從性。

美國是一個至關重要的市場，其驅動力在於個人對非侵入性、無痛醫療解決方案的偏好。無針給藥技術透過提供比傳統注射更舒適的替代方案，滿足了這項需求。此外，各公司正投入資源研發創新方法，以提高精準度、減少不適感並增強病患遵從性。提供有效、非侵入性治療方案的創新專利技術正日益普及，進而改善慢性病管理並拓展市場。 2025年，More Impact AG公司憑藉其子公司The Key Unternehmensberatung GmbH開發的無針注射技術「Speedinject」獲得了美國專利。此創新系統利用電磁技術實現精準、無痛的藥物輸送，尤其適用於糖尿病和減重治療。

無針給藥技術市場趨勢：

慢性病盛行率增加

糖尿病、癌症和心血管疾病等慢性疾病通常需要長期用藥，而無針給藥系統為此類治療提供了一種便捷高效的解決方案。根據國際糖尿病聯盟 (IDF) 最新發布的《糖尿病地圖集》（2025 年版），預計到 2050 年，八分之一的成年人（約 8.53 億人）將患有糖尿病，增幅高達 46%。隨著人們對替代性、非侵入性且無痛的給藥系統的需求日益成長，這些技術恰好能夠滿足越來越多需要持續規律用藥的患者的需求。無針給藥系統能夠提高舒適度，並降低傳統注射技術的風險和不適。因此，這些系統正逐漸被廣泛接受，既滿足了醫療專業人員對可靠高效給藥方式的需求，也滿足了患者對更佳治療體驗的渴望。無針給藥技術的普及得益於人們健康意識的提高和慢性病治療需求的不斷成長。

人口老化的過程

老年人口的成長推動了對無針給藥技術的需求。這些系統為老年人慢性病管理提供了便捷無痛的解決方案。世界衛生組織（世衛組織）估計，全球60歲以上人口將從2023年的11億增加到2030年的14億。隨著老年人口的成長，人們對高效、易用且創傷更小的醫療方案的需求日益成長。老年人通常患有多種慢性疾病，例如糖尿病、關節炎和心臟病，需要長期服藥。無針給藥系統提供了一種便捷無痛的選擇，減少了傳統注射帶來的不適和風險。這些創新技術滿足了老年患者的需求，對他們而言，由於害怕注射、身體障礙或認知能力下降等原因，定期注射對他們來說是一項挑戰。隨著世界老化，無針系統正變得至關重要，使老年人的給藥更加便捷。

藥物輸送裝置的技術進步

無針給藥系統的持續技術進步提高了給藥效率、準確性、安全性和患者舒適度，使其更加實用且更具吸引力。噴射注射器、微針和經皮吸收貼片的進步提高了藥物劑量的精確度和易用性。此外，電磁學和各種創新技術的進步提高了這些設備的整體效率，使其得到更廣泛的認可。隨著這些設備不斷發展以滿足不同治療領域的需求，它們持續吸引醫療專業人員和患者的關注，市場佔有率不斷擴大。相關人員目前的研究活動有望​​催生出更先進、更容易使用的系統，為各種醫療治療提供更完善的解決方案。 2024年，麻省理工學院和諾和諾德公司的研究人員宣布推出一種受魷魚啟發的無針給藥系統。這項微噴射技術利用高壓噴射將胰島素等大分子直接輸送到胃腸道，其生物利​​用度與傳統注射相當。這款創新設備旨在提高患者的遵守用藥，並為針刺治療提供更安全、更有效的替代方案。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球無針藥物輸送技術市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 吸入器
  • 噴射注射器
  • 新針
  • 經皮吸收貼劑
  • 其他

第7章 市場區隔：依應用領域分類

  • 疫苗接種
  • 疼痛管理
  • 胰島素輸送
  • 其他

第8章 市場區隔：依最終用戶分類

  • 醫院和診所
  • 居家醫療環境
  • 研究所
  • 學術機構
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章：促進、抑制與機遇

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Akra Dermojet
    • Antares Pharma Inc.（Halozyme Therapeutics Inc.）
    • Crossject
    • Mika Medical Co.
    • PharmaJet
    • Portal Instruments Inc.
Product Code: SR112026A7818

The global needle-free drug delivery technology market size was valued at USD 4.8 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 7.1 Billion by 2034, exhibiting a CAGR of 4.25% from 2026-2034. North America currently dominates the market, holding a market share of 43.4% in 2025. The market is driven by rising demand for painless administration methods, the growing awareness about infection control, and increasing adoption of self-administration systems. Advancements in biotechnology and device precision enhance patient compliance and treatment outcomes are further contributing to the needle-free drug delivery technology market share.

The rising worldwide occurrence of chronic illnesses, especially diabetes, is driving the need for effective, painless medication delivery methods. Needle-free technologies provide an option to traditional injection techniques, improving patient compliance and comfort. With chronic conditions requiring regular medication, needle-free systems offer a more convenient alternative, enhancing patient quality of life. Apart from this, ongoing advancements in jet injectors, transdermal patches, and various needle-free devices are enhancing precision, safety, and dosage accuracy. These innovations improve drug absorption, minimize waste, and guarantee reliable delivery, boosting treatment effectiveness and patient adherence. Additionally, the integration of needle-free drug delivery systems with digital health solutions is enabling real-time monitoring, data collection, and personalized treatment plans, which improve patient outcomes and adherence.

The United States is a crucial segment in the market, driven by the individual preference for non-invasive, pain-free medical solutions. Needle-free drug delivery technologies meet this demand by offering a more comfortable alternative to traditional injections. In addition, businesses are allocating resources to innovative approaches that increase accuracy, lessen discomfort, and boost patient adherence. Innovative patented technologies providing effective, non-invasive treatment solutions are becoming more popular, enabling improved management of chronic illnesses and broadening market offerings. In 2025, More Impact AG secured a US patent for its Speedinject needle-free injection technology, developed by its subsidiary The Key Unternehmensberatung GmbH. This innovative system uses electromagnetism for precise, painless drug delivery, especially targeting diabetes and weight loss treatments.

NEEDLE-FREE DRUG DELIVERY TECHNOLOGY MARKET TRENDS:

Rising Prevalence of Chronic Diseases

Chronic conditions like diabetes, cancer, and cardiovascular diseases (CVDs), often require long-term medication, and needle-free systems offer a convenient and efficient solution for managing such treatments. The recent International Diabetes Federation (IDF) Diabetes Atlas (2025) estimates that by 2050, 1 in 8 adults, or around 853 million individuals, will have diabetes, marking a 46% rise. As the demand rises for alternative, non-invasive, and pain-free drug delivery systems, these technologies are ideally positioned to cater to the growing number of individuals needing consistent, regular medication. Needle-free systems enhance comfort, reducing the risks and discomfort linked to conventional injection techniques. As a result, these systems are being adopted, meeting the demands of healthcare practitioners for dependable and efficient delivery methods, while fulfilling patients' demand for enhanced treatment experiences. There is a higher adoption of needle-free drug administration owing to increased health awareness and the growing need for chronic illness treatment.

Growing Geriatric Population

The increasing elderly population is driving the need for needle-free drug delivery technologies as these systems offer a convenient, pain-free solution for managing chronic conditions in older adults. The World Health Organization (WHO) estimates that the population aged 60 and above globally will rise from 1.1 billion in 2023 to 1.4 billion by 2030. With the rise of the senior population, the need for efficient, user-friendly, and minimally invasive healthcare options rises. Elderly people frequently experience several chronic illnesses like diabetes, arthritis, and heart diseases, necessitating ongoing medication. Needle-free drug delivery systems provide a convenient, painless option, lowering the discomfort and dangers linked to conventional injections. These innovations address the requirements of senior patients who might find routine injections challenging because of needle fears, physical constraints, or mental disabilities. As the global population ages, needle-free systems are becoming vital, facilitating easier and more convenient drug delivery for the elderly.

Technological Advancements in Drug Delivery Devices

Ongoing technological progress in needle-free drug delivery systems are enhancing delivery effectiveness, accuracy, safety, and patient comfort, making these systems more feasible and appealing. Advancements in jet injectors, microneedles, and transdermal patches are resulting in enhanced precision in drug dosage and better user-friendliness. Moreover, progress in electromagnetism and various innovative technologies is improving the overall efficiency of these devices, leading to their higher acceptance. As these devices develop to fulfill the needs of different therapeutic fields, they consistently draw interest from healthcare professionals and patients alike, enhancing their market presence. Current research initiatives by industry stakeholders are expected to lead to the launch of more sophisticated and user-friendly systems, which are providing enhanced solutions for various medical treatments. In 2024, researchers from MIT and Novo Nordisk unveiled a squid-inspired needle-free drug delivery system. This microjet technology used high-pressure jets to deliver macromolecules like insulin directly into the gastrointestinal tract, achieving bioavailability comparable to traditional injections. The innovative devices aimed to enhance patient compliance and offer a safer, more efficient alternative to needle-based treatments.

NEEDLE-FREE DRUG DELIVERY TECHNOLOGY INDUSTRY SEGMENTATION:

Analysis by Product:

  • Inhaler
  • Jet Injector
  • Novel Needles
  • Transdermal Patch
  • Others

Jet injector leads the market with a share of 39.5%, as it can administer medication without needles, providing a painless and non-invasive experience for patients. This instrument provides exceptional accuracy in medication administration, improving patient safety and treatment effectiveness. Jet injector is especially preferred due to its user-friendliness, quick delivery, and reduced chance of needle-stick injuries, making it ideal for healthcare workers and self-administration. Its flexibility in providing a broad spectrum of medications, such as vaccines, insulin, and other biologics, enhances their attractiveness in different therapeutic domains. The rising need for self-care, especially in managing chronic illnesses, is resulting in a greater utilization of jet injector, which offers a handy, portable, and efficient option for patients. Additionally, progress in jet injector technology persists in enhancing precision, minimizing drug waste, and improving the overall user experience.

Analysis by Application:

  • Vaccine Delivery
  • Pain Management
  • Insulin Delivery
  • Others

Insulin delivery represents the largest segment, accounting for 46.3%, driven by the increasing incidence of diabetes and the heightened demand for efficient, pain-free, and easy-to-use administration systems. Needle-free technology is becoming more significant in this segment, as it improves patient adherence, lessens discomfort, and decreases risks linked to conventional injections. Ongoing improvements in precision delivery, dosage accuracy, and safety measures are supporting the implementation throughout healthcare environments. The growing trend of self-administration and home care are catalyzing the demand for insulin delivery devices, matching patient desires for convenience and effectiveness. A strong emphasis on managing chronic illnesses, along with supportive healthcare programs advancing contemporary drug delivery techniques, is contributing to the market growth. Furthermore, continuous research and product development initiatives by industry leaders guarantee steady enhancements in usability, reliability, and cost-efficiency. The needle-free drug delivery technology market forecast predicts sustained growth as these advancements continue to drive demand across diverse therapeutic applications.

Analysis by End User:

  • Hospitals and Clinics
  • Homecare Settings
  • Research Laboratories
  • Academics
  • Others

Hospitals and clinics hold the biggest market share of 55.1%, because of their established infrastructure, access to skilled healthcare professionals, and superior diagnostic and treatment capabilities. These establishments function as main hubs for patient treatment, guaranteeing safe, precise, and effective medication delivery. A strong emphasis on quality care, infection management, and patient comfort supports the implementation of contemporary drug delivery technologies in these environments. Incorporating advanced technology and following strict regulatory guidelines further improve reliability and clinical results. Ongoing employee training and a focus on accuracy in care facilitate the adoption of cutting-edge solutions. Hospitals and clinics gain from steady patient traffic, efficient supply chains, and strong collaboration with manufacturers, enabling quicker technology implementation. Their dedication to enhancing treatment effectiveness, minimizing procedural risks, and fostering value-based healthcare plays a key role in their leading position in the market. This aligns with the current needle-free drug delivery technology market trend, highlighting increasing reliance on innovative healthcare solutions.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America dominates the market with a share of 43.4%, owing to its developed healthcare infrastructure, significant uptake of innovative medical technologies, and a firm focus on patient-centered treatment methods. The area gains from significant funding in research operations, fostering ongoing advancements in drug delivery technologies. Supportive reimbursement strategies and beneficial regulatory structures result in the introduction of innovative solutions, while vigorous clinical trial efforts expedite product validation and market authorization. The existence of established pharmaceutical and biotechnology firms boosts technological integration and market competitiveness. Moreover, rising awareness about minimally invasive treatments, heightened emphasis on preventive health measures, and the growing demand for precision-oriented medication delivery support the regional dominance. In 2024, NuGen Medical Devices launched the InsuJet needle-free insulin delivery device in Canada, following its global approval in 42 countries. The device, which used a spring-loaded mechanism to deliver insulin painlessly and efficiently, received initial orders worth $670,000. Major Canadian pharmacy networks offered the device, making it accessible to over 12,000 pharmacies across the country.

KEY REGIONAL TAKEAWAYS:

UNITED STATES NEEDLE-FREE DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS

In North America, the market portion held by the United States was 82.60%, driven by increasing patient demand for non-invasive, pain-free treatment methods and the rising incidence of chronic diseases that necessitate regular drug delivery. As stated by the Centers for Disease Control and Prevention (CDC), around 129 million people in the United States have at least one significant chronic condition, and 42% of individuals experience two or more conditions, and 12% deal with as many as five. With a growing number of patients dealing with conditions like diabetes, arthritis, and hormonal imbalances, there is a higher need for alternatives to standard injections, especially for individuals who have needle phobia or struggle with self-injection. The rising trend of self-administration and home care is driving the need for accessible, safe, and effective drug delivery systems that lessen reliance on healthcare providers. Additionally, innovations in jet injectors, microneedle patches, inhalable drugs, and transdermal systems are broadening the options for administering various medications without requiring needles. Needle-free systems also minimize the likelihood of needle-stick injuries and cross-contamination, enhancing their appeal to both patients and healthcare professionals. Many pharmaceutical firms in the area are progressively allocating resources to research and development (R&D) for novel delivery technologies aimed at improving therapeutic results and setting their products apart.

EUROPE NEEDLE-FREE DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS

The growth of the market in Europe is driven by heightened demand for patient-focused, non-invasive treatment options, increased healthcare awareness, and the prevalence of chronic illnesses throughout the region. A large segment of the population coping with ailments like diabetes, heart diseases, and lung disorders is driving the need for drug delivery systems that increase convenience, minimize discomfort, and boost compliance with treatment. The World Heart Federation states that more than 60 million people in Europe are affected by cardiovascular diseases (CVDs). Additionally, CVDs account for over 1.7 million fatalities each year in the area. Moreover, widespread worries about needle injuries, infections, and fear of needles are driving healthcare providers and institutions to implement safer and more user-friendly options. Innovations in microneedle patches, jet injectors, and inhalable drug delivery systems are enabling the administration of various therapeutics without the use of needles, enhancing bioavailability and patient adherence. Additionally, the robust regulatory framework of the region and its support for innovation are motivating pharmaceutical firms to invest in creating and marketing advanced drug delivery technologies.

ASIA PACIFIC NEEDLE-FREE DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS

The market in the Asia Pacific is growing due to heightened healthcare awareness, an increasing population suffering from chronic illnesses, and a higher demand for non-invasive treatment options. Nations like China, India, and Japan are witnessing a notable increase in ailments such as diabetes, asthma, and heart diseases that necessitate consistent medication use. For example, the quantity of people aged 20-79 years with diabetes in China, India, and Japan was 148.0 Million, 89.8 Million, and 10.8 Million, respectively, in 2024, according to the International Diabetes Federation (IDF). Additionally, there is an inclination toward needle-free systems that alleviate pain, improve convenience, and lower the chances of needle-stick injuries. Moreover, the rising middle-class demographics, higher healthcare spending, and governmental initiatives to enhance access to medical technologies are further offering a favorable needle-free drug delivery technology market outlook. In addition, the rise in the use of self-administration and home healthcare solutions is driving the demand for accessible drug delivery systems.

LATIN AMERICA NEEDLE-FREE DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS

The Latin America market for needle-free drug delivery technology is witnessing strong growth fueled by the increasing prevalence of chronic diseases, heightened healthcare awareness, and the demand for more accessible and patient-centric treatment choices. Many patients in the area choose non-invasive drug delivery options to reduce pain, anxiety from needles, and the possibility of infections. The growth of home healthcare and self-care methods is also encouraging the adoption of needle-free systems, especially for managing diseases like diabetes and asthma. According to the International Diabetes Federation (IDF), the rates of diabetes among adults in Argentina, Brazil, and Chile were 14%, 10.6%, and 12.2%, respectively, in 2024. In addition, enhancing healthcare infrastructure and increasing the availability of innovative delivery devices are also supporting the market growth and broadening access to advanced treatment options.

MIDDLE EAST AND AFRICA NEEDLE-FREE DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS

The needle-free drug delivery technology market growth in the Middle East and Africa is influenced by the rising healthcare investments and the increasing incidence of chronic diseases in the area. For example, the Government of the Kingdom of Saudi Arabia designated SR 86,253,063 for the Ministry of Health in 2024, representing 7% of the national budget. With the modernization of healthcare systems in the region, there is a higher focus on implementing cutting-edge technologies that enhance patient adherence and lower the risks linked to conventional injections. Needle-free medication administration is gaining popularity for its capacity to reduce pain, prevent needle-stick injuries, and aid extensive vaccination initiatives. Besides this, governments and private healthcare organizations are concentrating on enhancing access to advanced medical solutions, further encouraging the use of needle-free technologies among both urban and rural communities.

COMPETITIVE LANDSCAPE:

Major participants in the market are concentrating on product innovation, strategic partnerships, and technological progress to improve delivery efficiency and patient comfort. They are committing resources to research operations to create precision-focused systems, lower production expenses, and guarantee adherence to regulations. Numerous companies are broadening their international footprint via collaborations, mergers, and distribution deals to enhance market access. Ongoing advancements in device design, safety, and usability continue to be a focus to address the growing demand in various therapeutic fields. For example, in 2024, IntegriMedical launched India's first Needle-Free Injection System (N-FIS), offering a pain-reducing alternative for injections, especially for children and needle-phobic patients. With CDSCO approval and a strategic partnership with Serum Institute of India, the system had over 35,000 injections administered. The company aimed to expand in India and Europe, focusing on safer, patient-friendly drug delivery.

The report provides a comprehensive analysis of the competitive landscape in the needle-free drug delivery technology market with detailed profiles of all major companies, including:

  • Akra Dermojet
  • Antares Pharma Inc. (Halozyme Therapeutics Inc.)
  • Crossject
  • Mika Medical Co.
  • PharmaJet
  • Portal Instruments Inc.

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Needle-free Drug Delivery Technology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Inhaler
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Jet Injector
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Novel Needles
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Transdermal Patch
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Vaccine Delivery
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pain Management
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Insulin Delivery
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End Users

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Homecare Settings
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Research Laboratories
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Academics
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Akra Dermojet
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Antares Pharma Inc. (Halozyme Therapeutics Inc.)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Crossject
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Mika Medical Co.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 PharmaJet
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Portal Instruments Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio

List of Figures

  • Figure 1: Global: Needle-free Drug Delivery Technology Market: Major Drivers and Challenges
  • Figure 2: Global: Needle-free Drug Delivery Technology Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Needle-free Drug Delivery Technology Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Needle-free Drug Delivery Technology Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Needle-free Drug Delivery Technology Market: Breakup by End Users (in %), 2025
  • Figure 7: Global: Needle-free Drug Delivery Technology Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Needle-free Drug Delivery Technology (Inhaler) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Needle-free Drug Delivery Technology (Inhaler) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Needle-free Drug Delivery Technology (Jet Injector) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Needle-free Drug Delivery Technology (Jet Injector) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Needle-free Drug Delivery Technology (Novel Needles) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Needle-free Drug Delivery Technology (Novel Needles) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Needle-free Drug Delivery Technology (Transdermal Patch) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Needle-free Drug Delivery Technology (Transdermal Patch) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Needle-free Drug Delivery Technology (Other Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Needle-free Drug Delivery Technology (Other Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Needle-free Drug Delivery Technology (Vaccine Delivery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Needle-free Drug Delivery Technology (Vaccine Delivery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Needle-free Drug Delivery Technology (Pain Management) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Needle-free Drug Delivery Technology (Pain Management) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Needle-free Drug Delivery Technology (Insulin Delivery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Needle-free Drug Delivery Technology (Insulin Delivery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Needle-free Drug Delivery Technology (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Needle-free Drug Delivery Technology (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Needle-free Drug Delivery Technology (Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Needle-free Drug Delivery Technology (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Needle-free Drug Delivery Technology (Homecare Settings) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Needle-free Drug Delivery Technology (Homecare Settings) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Needle-free Drug Delivery Technology (Research Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Needle-free Drug Delivery Technology (Research Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Needle-free Drug Delivery Technology (Academics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Needle-free Drug Delivery Technology (Academics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Needle-free Drug Delivery Technology (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Needle-free Drug Delivery Technology (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: North America: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: North America: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: United States: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: United States: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Canada: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Canada: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Asia-Pacific: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Asia-Pacific: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: China: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: China: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Japan: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Japan: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: India: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: India: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: South Korea: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: South Korea: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Australia: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Australia: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Indonesia: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Indonesia: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Others: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Others: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Europe: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Europe: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Germany: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Germany: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: France: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: France: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: United Kingdom: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: United Kingdom: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Italy: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Italy: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Spain: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Spain: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Russia: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Russia: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Others: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Others: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Latin America: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Latin America: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Brazil: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Brazil: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Mexico: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Mexico: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Others: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Others: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Middle East and Africa: Needle-free Drug Delivery Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Middle East and Africa: Needle-free Drug Delivery Technology Market: Breakup by Country (in %), 2025
  • Figure 84: Middle East and Africa: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Global: Needle-free Drug Delivery Technology Industry: Drivers, Restraints, and Opportunities
  • Figure 86: Global: Needle-free Drug Delivery Technology Industry: Value Chain Analysis
  • Figure 87: Global: Needle-free Drug Delivery Technology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Needle-free Drug Delivery Technology Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Needle-free Drug Delivery Technology Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Needle-free Drug Delivery Technology Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Needle-free Drug Delivery Technology Market Forecast: Breakup by End Users (in Million USD), 2026-2034
  • Table 5: Global: Needle-free Drug Delivery Technology Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Needle-free Drug Delivery Technology Market: Competitive Structure
  • Table 7: Global: Needle-free Drug Delivery Technology Market: Key Players